Home/Filings/4/0000950170-25-111738
4//SEC Filing

Kooij Louise Frederika 4

Accession 0000950170-25-111738

CIK 0001936258other

Filed

Aug 26, 8:00 PM ET

Accepted

Aug 27, 5:08 PM ET

Size

5.0 KB

Accession

0000950170-25-111738

Insider Transaction Report

Form 4
Period: 2025-08-25
Kooij Louise Frederika
Chief Accounting Officer
Transactions
  • Sale

    Ordinary Shares

    2025-08-25$24.86/sh8,269$205,56715,000 total
Footnotes (1)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.74 per share to $24.92 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold in each transaction.

Documents

1 file

Issuer

NewAmsterdam Pharma Co N.V.

CIK 0001936258

Entity typeother

Related Parties

1
  • filerCIK 0002004379

Filing Metadata

Form type
4
Filed
Aug 26, 8:00 PM ET
Accepted
Aug 27, 5:08 PM ET
Size
5.0 KB